3,400-year-old Egyptian town with links to King Tutankhamun unearthed near Alexandria
Detailed in a new study published in Antiquity, the mud-brick ruins are believed to date back to Egypt's 18th Dynasty (circa 1550–1292 BCE), a period known for its wealth, power, and dramatic shifts in religious ideology.
The site, known as Kom el-Nugus, lies 27 miles west of Alexandria, perched on a rocky ledge between the Mediterranean Sea and Lake Mariout. Although excavations began in 2013, it was long assumed that the area had only been settled during the Hellenistic period, when the Greeks arrived around 332 BCE.
'The discovery of New Kingdom remains at the site was a great surprise,' lead archaeologist Sylvain Dhennin of the University of Lyon and the French National Centre for Scientific Research told the New Scientist. 'This discovery completely revises the history of Egypt's western frontier in the New Kingdom.'
Among the most noteworthy finds found during the excavation were amphora jar fragments stamped with the name Merytaton, who was believed to the eldest daughter of revolutionary pharaoh Akhenaten and his queen, Nefertiti - and thus making her the sister or half-sister of Tutankhamun. The markings indicate the settlement could have been a wine production facility that may have been dedicated to her, suggesting that royal branding and product endorsements existed in ancient Egypt.
"The presence of this stamp probably indicates the production of wine belonging to a royal estate" study author Sylvain Dhennin, an archaeologist with the French National Center for Scientific Research (CNRS), told Live Science. "The vineyards on the margins of Egypt were probably protected by the military and formed part of a pioneering front to occupy this region towards the desert."
Other discoveries include fragments of a stele bearing the cartouches of Pharaoh Seti II (r. 1203–1197 BCE), and architectural remnants linked to a temple honouring Ramesses II - a ruler often speculated to be the pharaoh of the biblical Exodus.
While the full scale of the settlement remains unknown, the presence of a meticulously designed street, cleverly sloped to drain water and protect buildings from erosion, points to a town of significant size and sophistication.
Related
Archaeologists unearth 3,200-year-old tomb linked to ancient Egypt's military elite
The Bashiri mystery: A 2,300-year-old Egyptian mummy that no archaeologist dares to open
The discovery of the settlement adds to a series of major Egyptian archaeological finds this year. Just last month, archaeologists unearthed the tomb of Pharaoh Thutmose II - the first pharaonic burial site found since Tutankhamun's in 1922.
Discovered by a joint British-Egyptian team led by Dr Piers Litherland, the tomb was hidden away in the Western Valleys of the Theban Necropolis, near Luxor.
Mohamed Ismail Khaled, the secretary general of Egypt's Supreme Court of Antiquities, said in a statement that the discovery was 'one of the most significant archeological breakthroughs in recent years.'
Days later, the same team announced they may have located a second tomb belonging to Thutmose II, buried 23 metres beneath a carefully disguised mound of rubble, limestone, ash, and mud plaster. Litherland believes the tomb could contain the pharaoh's mummified remains and grave goods. 'The best candidate for what is hidden underneath this enormously expensive, in terms of effort, pile is the second tomb of Thutmose II,' he told The Observer.
And earlier this year, a French-Swiss archaeological team in Egypt made another remarkable discovery - the tomb of a high-ranking wizard-doctor who served the pharaohs some 4,000 years ago. Inscriptions identify the tomb's owner as Tetinebefou, a celebrated doctor during the reign of King Pepi II (circa 2305–2118 BC).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scientific American
3 days ago
- Scientific American
New Brain Device Is First to Read Out Inner Speech
After a brain stem stroke left him almost entirely paralyzed in the 1990s, French journalist Jean-Dominique Bauby wrote a book about his experiences—letter by letter, blinking his left eye in response to a helper who repeatedly recited the alphabet. Today people with similar conditions often have far more communication options. Some devices, for example, track eye movements or other small muscle twitches to let users select words from a screen. And on the cutting edge of this field, neuroscientists have more recently developed brain implants that can turn neural signals directly into whole words. These brain-computer interfaces (BCIs) largely require users to physically attempt to speak, however—and that can be a slow and tiring process. But now a new development in neural prosthetics changes that, allowing users to communicate by simply thinking what they want to say. The new system relies on much of the same technology as the more common 'attempted speech' devices. Both use sensors implanted in a part of the brain called the motor cortex, which sends motion commands to the vocal tract. The brain activation detected by these sensors is then fed into a machine-learning model to interpret which brain signals correspond to which sounds for an individual user. It then uses those data to predict which word the user is attempting to say. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. But the motor cortex doesn't only light up when we attempt to speak; it's also involved, to a lesser extent, in imagined speech. The researchers took advantage of this to develop their 'inner speech' decoding device and published the results on Thursday in Cell. The team studied three people with amyotrophic lateral sclerosis (ALS) and one with a brain stem stroke, all of whom had previously had the sensors implanted. Using this new 'inner speech' system, the participants needed only to think a sentence they wanted to say and it would appear on a screen in real time. While previous inner speech decoders were limited to only a handful of words, the new device allowed participants to draw from a dictionary of 125,000 words. 'As researchers, our goal is to find a system that is comfortable [for the user] and ideally reaches a naturalistic ability,' says lead author Erin Kunz, a postdoctoral researcher who is developing neural prostheses at Stanford University. Previous research found that 'physically attempting to speak was tiring and that there were inherent speed limitations with it, too,' she says. Attempted speech devices such as the one used in the study require users to inhale as if they are actually saying the words. But because of impaired breathing, many users need multiple breaths to complete a single word with that method. Attempting to speak can also produce distracting noises and facial expressions that users find undesirable. With the new technology, the study's participants could communicate at a comfortable conversational rate of about 120 to 150 words per minute, with no more effort than it took to think of what they wanted to say. Like most BCIs that translate brain activation into speech, the new technology only works if people are able to convert the general idea of what they want to say into a plan for how to say it. Alexander Huth, who researches BCIs at the University of California, Berkeley, and wasn't involved in the new study, explains that in typical speech, 'you start with an idea of what you want to say. That idea gets translated into a plan for how to move your [vocal] articulators. That plan gets sent to the actual muscles, and then they carry it out.' But in many cases, people with impaired speech aren't able to complete that first step. 'This technology only works in cases where the 'idea to plan' part is functional but the 'plan to movement' part is broken'—a collection of conditions called dysarthria—Huth says. According to Kunz, the four research participants are eager about the new technology. 'Largely, [there was] a lot of excitement about potentially being able to communicate fast again,' she says—adding that one participant was particularly thrilled by his newfound potential to interrupt a conversation—something he couldn't do with the slower pace of an attempted speech device. To ensure private thoughts remained private, the researchers implemented a code phrase: 'chitty chitty bang bang.' When internally spoken by participants, this would prompt the BCI to start or stop transcribing. Brain-reading implants inevitably raise concerns about mental privacy. For now, Huth isn't concerned about the technology being misused or developed recklessly, speaking to the integrity of the research groups involved in neural prosthetics research. 'I think they're doing great work; they're led by doctors; they're very patient-focused. A lot of what they do is really trying to solve problems for the patients,' he says, 'even when those problems aren't necessarily things that we might think of,' such as being able to interrupt a conversation or 'making a voice that sounds more like them.' For Kunz, this research is particularly close to home. 'My father actually had ALS and lost the ability to speak,' she says, adding that this is why she got into her field of research. 'I kind of became his own personal speech translator toward the end of his life since I was kind of the only one that could understand him. That's why I personally know the importance and the impact this sort of research can have.' The contribution and willingness of the research participants are crucial in studies like this, Kunz notes. 'The participants that we have are truly incredible individuals who volunteered to be in the study not necessarily to get a benefit to themselves but to help develop this technology for people with paralysis down the line. And I think that they deserve all the credit in the world for that.'
New York Post
4 days ago
- New York Post
Massive jellyfish swarm forces shutdown of major nuclear power plant
Four reactors at France's Gravelines nuclear power plant, located along the English Channel, were temporarily shut down over the weekend after a swarm of jellyfish threatened to clog critical water intake systems. According to the plant's operator, several of the facility's production units went offline after jellyfish were detected in the filter drums of the plant's pumping stations. Advertisement The French multinational electric utility company said the pumping stations, located in the non-nuclear section of the site, supply cooling water essential for the facility's operation. 'They had no impact on the safety of the facilities, the safety of personnel, or the environment,' EDF said in a statement. The Gravelines nuclear power plant is one of the largest nuclear facilities in Western Europe and has been connected to the grid since the 1980s. The impacts of jellyfish on coastal power plants is not without precedent, as there have been similar incidents reported around the globe during the summer months. Advertisement Along the English Channel, jellyfish sightings are frequent and can occasionally result in beach closures due to safety concerns for swimmers. Much of the North Sea and Mediterranean Sea have experienced above-average water temperatures this year, fueling extensive heat waves and creating more favorable conditions for jellyfish. Previous studies have suggested warmer seas can also accelerate jellyfish breeding cycles, increasing the likelihood of large swarms. The production units at the nuclear power plant went offline after jellyfish were seen in the filter drums of the pumping stations. AFP via Getty Images Advertisement In June, several French nuclear reactors reduced output to limit the amount of discharge into waterways because of record-breaking sea surface temperatures. The country's regulations require operators to avoid releasing waste, as overheated water can harm aquatic life. Warm water is known to place additional stress on marine species, lower oxygen levels and disrupt sensitive ecosystems. Jellyfish sightings are very common along the English Channel, which has led to beach closures across the area. AFP via Getty Images Advertisement Despite the recent interruptions at the Gravelines plant, France has not reported issues meeting the demand for electricity. According to the World Nuclear Association, the country generates about 70% of its electricity from nuclear energy and frequently exports surplus power to neighboring nations. EDF said plant teams remain mobilized and are conducting diagnostics and technical interventions to clear the intake systems and safely restart the affected units. The utility did not say when it expects to have the reactors back online to generate power for the grid.
Politico
4 days ago
- Politico
Bhattacharya and Kennedy split on mRNA cuts
AROUND THE AGENCIES National Institutes of Health Director Jay Bhattacharya is making the case that mRNA vaccine technology is 'promising, but not yet ready for prime time.' He cites a lack of public trust in the technology as the reason his boss, Health Secretary Robert F. Kennedy Jr.,recently canceled $500 million in mRNA vaccine development projects. Bhattacharya weighed in on Kennedy's decision in a conversation over the weekend with Steve Bannon, the longtime Trump ally and prominent MAGA figure, on Bannon's 'War Room' podcast: 'The reason that he did that — and I think it's very important for people to understand — as far as public health goes for vaccines, the mRNA platform is no longer viable,' Bhattacharya said. 'You can't have a platform where such a large fraction of the population distrusts the platform, if you're going to use it for vaccines, and expect it to work.' But, but, but: Kennedy, who has long been suspicious of the mRNA vaccine platform, offered an explanation for the funding cuts that contradicts Bhattacharya's reasoning. 'After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses,' Kennedy said in a video posted on social media last week, referring to Covid-19 and flu mRNA vaccines. Big picture: Scientists and drugmakers worry that Kennedy's skepticism of mRNA could stifle cancer treatment developments, our Lauren Gardner reports. mRNA technology can instruct the immune system to attack problem proteins, so it holds promise as a customized treatment for rare cancers and diseases. As such, dozens of mRNA therapies are being studied or are in the drug-development pipeline. Bhattacharya seemed aware of the technology's use beyond flu and Covid vaccines. After telling Bannon that mRNA technology wasn't ready for widespread vaccine use, he added: 'For cancer, maybe it's another story.' WELCOME TO FUTURE PULSE This is where we explore the ideas and innovators shaping health care. A swarm of jellyfish shut down reactors at a French nuclear power station, Ketrin Jochecová, our POLITICO colleague in Europe, reports. Share any thoughts, news, tips and feedback with Ruth Reader at rreader@ or Erin Schumaker at eschumaker@ Want to share a tip securely? Message us on Signal: RuthReader.02 or ErinSchumaker.01. OPERATING ROOM A large-scale study of New York's Mount Sinai Health System suggests that artificial intelligence could help emergency departments better handle their patient loads. In the study, researchers from Mount Sinai trained an AI model on 1.8 million emergency department visits between January 2019 and December 2023. Then they tested the model by comparing it with two months' worth of nurse triage assessments of nearly 50,000 patient visits across the system's urban and suburban hospitals. The result: Nurse predictions were 81.6 percent accurate, while the AI model's assessments were 85.4 percent accurate. The study, published in the journal Mayo Clinic Proceedings: Digital Health in July, had a few limitations, the authors noted, including that the research was conducted at a single health system over a short time span. Outcomes might differ in another setting, and longer-term trends could yield different results. Bird's eye view: 'The strength of this approach is its ability to turn complex data into timely, actionable insights for clinical teams — freeing them up to focus less on logistics and more on delivering the personal, compassionate care that only humans can provide,' Dr. Eyal Klang, study co-author and director of the Generative AI Research Program at Mount Sinai, said in a statement.
